According to state authorities, 10 million doses of vaccine will be given by the pharmaceutical company Cadila Healthcare in October. Zydus Cadila is likely to be in use in early October as a needle-free coronavirus vaccine, ZyCoV-D. The vaccine was approved for adolescents aged 12 to 18 years of age. The price details of the vaccine have not yet been published, however. “The debate on ZyCoV-D pricing has been underway. Soon there will be a decision. We want the vaccine to be included in the national programme, “In an exclusive interview with ANI was Dr. VK Paul, Member (Health) of NITI Aayog.
ZyCoV-D
ZyCoV-D is the world’s first plasmid DNA vaccine for Covid-19. It’s a three-dose vaccine that will be administered on day zero, day 28, and day 56. The vaccine has been approved to be administered to adolescents between ages 12 and 18.
On 20 August, India’s drugs regulator approved the Zydus Cadila vaccine for emergency use.
Presently, Covishield, Covaxin, and Sputnik V vaccines are being administered to the eligible population above 18 years.
India’s cumulative COVID-19 vaccination coverage
Earlier today, India’s cumulative COVID-19 vaccination coverage surpassed 77.24 crores, of which 63,97,972 vaccine doses were administered in the last 24 hours. The new phase of universalization of COVID-19 vaccination commenced on June 21, 2021. The vaccination drive has been ramped up through the availability of more vaccines, advanced visibility of vaccine availability to States and UTs for enabling better planning by them and streamlining the vaccine supply chain.
Over 77.77 crore COVID-19 vaccine doses have been provided to states and union territories so far through free of cost channel, said the Ministry of Health and Family Welfare (MoHFW) on Friday.
